Ehmet Health is made up of skilled individuals derived from a wide spectrum of areas within health care. Each sharing one common vision, to bring a distinguished honesty to the medical device industry. Our team has a long history of involvement in the commercialization of medical devices with special focus in medical imaging and particle beam therapy. The high level of experience of our consortium of professionals leverages a wisdom that is beyond compare and unrivaled in the marketplace.
Management Team
Michael Teicher, Chief Executive Officer, brings over 20 years of experience in operations, financing and advising senior executives of medical companies on strategy,
operations, and capital market exposure. He most recently led the turnaround of one the largest point of care CT companies. With the previous proposed exit, Michael
and his team were contracted by one of the nation’s leading oncology providers and became integral members of the team that led the completion of a complex proton
system in addition to developing an innovative integrated CBCT imaging system that received FDA 510(k) clearance for use at that center.
Neal Clinthorne, Chief Technology Officer, is a world-renowned Research Professor Emeritus in Radiology
from the University of Michigan. He has written nearly 100 peer-reviewed articles, has been granted over 20 patents,
and has extensive experience in technology commercialization.
Kevin Murphy MBA, Chief Financial Officer, is a seasoned healthcare executive and has completed over $100 billion dollars in M&A has over 20 years on Wall Street in finance and operational administration in both the public and private sector. Kevin graduated from MIT and holds an MBA from Columbia.
Julia E. Williams, Global Executive Advisor & Director of Patient Advocacy, currently serves as a Regional Business Development Manager for
Clinical Laboratory & Anatomic Pathology within Academic Medicine & Community Healthcare. She is also a Managing Partner of JW Oncology Network, an executive retained firm dedicated to the advancement
of Oncology & Research Medicine. Julia remains very active in cancer and research through her industry advisory roles, consulting, cancer recruitment activities, and committee engagements. Julia is a
breast cancer survivor that believes in providing patients with quality care and the best options available. She is excited to be a part of the team and to work with other breast cancer survivors to develop this program for EHMEThealth.
Advisory Team
Our organization maintains a team of seasoned business advisors all whom have served in executive roles either within the fortune 100 sector or leading within their respective fields both in and outside of healthcare. Their insight has been critical as we navigate an ever-changing marketplace that will continue to evolve as we further globalize our brand.
Our advisory team is led by Mr. Gregory Lane Esq.
Greg Lane, Executive Vice President and Chief Administrative Officer of McLaren Health Care Corporation. Greg is a graduate of the University of Michigan
and received his Juris Doctorate from Detroit College of Law, where he served as Editor-in-Chief of the Law Review. Prior to joining McLaren,
Mr. Lane was in private legal practice and specialized in corporate and health care law. Mr. Lane is the past 2018-2019 Chair of Michigan Health and Hospital Association (MHA).
Mr. Lane also serves on several other Boards, and his professional affiliations include the State Bar of Michigan, the American Bar Association, the American Health Lawyers Association and the American College of Healthcare Executives.
